Rosenstein M, Rosenberg S A
J Natl Cancer Inst. 1984 May;72(5):1161-5.
T-cell clones that exhibited both lytic and proliferative activity for the syngeneic FBL-3 lymphoma were isolated from in vitro sensitization cultures. These clones were Lyt-2+ and proliferated specifically to the FBL-3 lymphoma but not to other tumors of C57BL/6 origin, allogeneic tumor, or C57BL/6 normal lymphocytes. Adoptive transfer of clones exhibiting both proliferative and cytotoxic activity prolonged survival and occasionally cured the animals of disseminated FBL-3 lymphomas, while T-cell clones exhibiting lytic but no proliferative activity conferred no survival benefit compared to the survival seen among animals receiving no treatment.
从体外致敏培养物中分离出了对同基因FBL-3淋巴瘤表现出溶解和增殖活性的T细胞克隆。这些克隆为Lyt-2+,能特异性地增殖于FBL-3淋巴瘤,而不增殖于C57BL/6来源的其他肿瘤、同种异体肿瘤或C57BL/6正常淋巴细胞。具有增殖和细胞毒性活性的克隆的过继转移延长了动物的生存期,并且偶尔能治愈播散性FBL-3淋巴瘤,而与未接受治疗的动物的生存期相比,表现出溶解活性但无增殖活性的T细胞克隆未带来生存益处。